Humanized CT26-hPD-L1 tumor cell line
![](https://cdn.prod.website-files.com/655b5a3d3d76e4eff6481da2/65b8bfab03e1c9348d5cf86f_cellule%201.png)
![](https://cdn.prod.website-files.com/655b5a3d3d76e4eff6481da2/65b8bfaacbee85e6e81e44c3_souris%201.png)
![](https://cdn.prod.website-files.com/655b5a3d3d76e4eff6481da2/65b8bfabf5f00b3aaec82ebf_rat%201.png)
Design of the CT26-hPD‑L1 cell line
The CT26.WT cell line was derived and subcloned from Balb/c murine colon carcinoma and forms tumors at high frequency when inoculated subcutaneously. We generated a CT26‑hPD‑L1 clonal cell line expressing human PD‑L1.
Applications in immuno-oncology
As for our MC38-hPD-L1 cell line, the CT26-hPD-L1 cell line can be used for in vivo tumor growth assays in syngeneic models and in vitro mechanistic studies.
CT26-Pd-l1 Knockout tumor cell line:
Use our CT26-Pd-l1 Knockout clones for target validation and mechanistic studies.
CT26-hPD-L1 features
We generated a CT26-hPD-L1 clonal cell line expressing high levels of human PD-L1, and forming solid tumors in vivo.
- They only express human PD-L1, as they are invalidated for murine Pd‑l1
- hPD-L1 is entirely humanized
- Strong and sustained expression of human PD-L1
![](https://cdn.prod.website-files.com/655dd3c88278aa64954052d4/65b1208112fc6da9dfeeea5e_img12.webp)
Validation
CT26‑hPD‑L1 cells express high levels of human PD‑L1
Expression analysis by flow cytometry. (A) mPd‑l1 expression in parental cell line CT26.WT and mPd‑l1 Knockout (KO) cells. (B) hPD‑L1 expression in human control cell line, CT26.WT parental cell line and CT26‑hPD‑L1 cell line. mPd‑l1 KO clone was generated, then human PD‑L1 was stably overexpressed in KO cells. Overexpressing clones were obtained through Neomycin selection.
Discover related products to
CT26-hPD-L1
Humanized CT26-hPD-L1 tumor cell line
Get in touch about
Let us know how we can help
Ultimate predictive models
Physiological relevance
Comprehensive and reliable validation data
Over 600 scientific articles based on our modelsScientific excellence
In-depth expertise in preclinical science, physiology, and model development
Unique R&D platform located in FranceCustomer-centric
Tailor-made approach to your needs
Strong emphasis on customer satisfactionCollaborative partner
Long-standing partnerships with 17 of the top 20 pharma companies
Co-development of innovative models for next-generation drugs
Guaranteed FTO/freedom to operate